These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26307969)

  • 41. Combined therapy (intravitreal bevacizumab plus verteporfin photodynamic therapy) versus intravitreal bevacizumab monotherapy for choroidal neovascularization due to age-related macular degeneration: a 1-year follow-up study.
    Saviano S; Leon PE; Mangogna A; Tognetto D
    Digit J Ophthalmol; 2016; 22(2):46-53. PubMed ID: 27582675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Photodynamic therapy in age-related macular degeneration--results of one year observation].
    Wykrota H; Gierek-Łapińska A
    Klin Oczna; 2002; 104(3-4):239-43. PubMed ID: 12608309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy.
    Moshfeghi DM; Kaiser PK; Grossniklaus HE; Sternberg P; Sears JE; Johnson MW; Ratliff N; Branco A; Blumenkranz MS; Lewis H
    Am J Ophthalmol; 2003 Mar; 135(3):343-50. PubMed ID: 12614752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMT-PDT).
    Lüke M; Ziemssen F; Völker M; Altpeter E; Beutel J; Besch D; Bartz-Schmidt KU; Gelisken F
    Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):745-54. PubMed ID: 19214552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two years follow-up outcome of verteporfin therapy for subfoveal choroidal neovascularization in pathologic myopia in Indian eyes.
    Hussain N; Khanna R; Das T; Narayanan R; Sunday OT; Bansal AG; Reddy R
    Indian J Ophthalmol; 2008; 56(6):465-8. PubMed ID: 18974516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subfoveal hemorrhage after verteporfin photodynamic therapy in treatment of choroidal neovascularization.
    Gelisken F; Inhoffen W; Karim-Zoda K; Grisanti S; Partsch M; Voelker M; Bartz-Schmidt KU
    Graefes Arch Clin Exp Ophthalmol; 2005 Mar; 243(3):198-203. PubMed ID: 15258778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Photodynamic therapy with delayed light application for the treatment of bilateral subfoveal choroidal neovascularization in age-related macular degeneration.
    Karacorlu M; Karacorlu S; Ozdemir H
    Jpn J Ophthalmol; 2003; 47(6):595-8. PubMed ID: 14636851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study.
    Pece A; Isola V; Vadalà M; Matranga D
    Retina; 2006 Sep; 26(7):746-51. PubMed ID: 16963846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration: results of an effectiveness study.
    Sharma S; Bakal J; Oliver-Fernandez A; Blair J
    Arch Ophthalmol; 2004 Jun; 122(6):853-6. PubMed ID: 15197060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Verteporfin PDT for subfoveal occult CNV in AMD: two-year results of a randomized trial.
    Kaiser PK;
    Curr Med Res Opin; 2009 Aug; 25(8):1853-60. PubMed ID: 19530976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Photodynamic therapy with verteporfin for recurrent choroidal neovascularisation (CNV) following prior argon laser coagulation].
    Gabel-Pfisterer A; Wehner A; Heimann H; Foerster MH; Wachtlin J
    Ophthalmologe; 2005 Jun; 102(6):592-6. PubMed ID: 15662503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy.
    Ladd BS; Solomon SD; Bressler NM; Bressler SB
    Am J Ophthalmol; 2001 Nov; 132(5):659-67. PubMed ID: 11704027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Photodynamic therapy for AMD and non-AMD patients: two-year results in Thais.
    Ratanasukon M; Bhurayanontachai P; Jirarattanasopa P
    J Med Assoc Thai; 2009 Mar; 92(3):367-72. PubMed ID: 19301730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined photodynamic therapy and intravitreal triamcinolone acetonide injection for neovascular age-related macular degeneration with pigment epithelium detachment.
    Axer-Siegel R; Ehrlich R; Avisar I; Kramer M; Rosenblatt I; Priel E; Weinberger D
    Ophthalmic Surg Lasers Imaging; 2006; 37(6):455-61. PubMed ID: 17152538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
    Lazic R; Gabric N
    Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.
    ; ;
    Retina; 2002 Feb; 22(1):6-18. PubMed ID: 11884872
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.
    Lam DS; Chan WM; Liu DT; Fan DS; Lai WW; Chong KK
    Br J Ophthalmol; 2004 Oct; 88(10):1315-9. PubMed ID: 15377558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update.
    Verteporfin Roundtable Participants
    Retina; 2005; 25(2):119-34. PubMed ID: 15689800
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Magnification requirement after photodynamic therapy with verteporfin for subfoveal predominantly classic choroidal neovascularization due to age-related macular degeneration.
    Thoelen AM; Bernasconi PP; Buser F; Fierz AB; Messmer EP
    Eur J Ophthalmol; 2005; 15(6):768-73. PubMed ID: 16329064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Photodynamic therapy with verteporfin for choroidal neovascularization associated with retinal pigment epithelial detachment in age-related macular degeneration.
    Pece A; Isola V; Vadalà M; Calori G
    Retina; 2007 Mar; 27(3):342-8. PubMed ID: 17460590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.